Home›Companies›Biotech & Pharma›Klothea BIO

Klothea Bio, Inc.

Develops experimental treatments for people affected by age-related diseases.

Updated Nov 9, 2026·Latest SEC filing Sep 8, 2026·Suggest an edit

About Klothea BIO

Klothea BIO is a private company based in Miami, Florida, incorporated in 2024 in Delaware. It has reported $6,885,000 raised in one offering on Form D since October 2024.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 11, 2024Oct 28, 2024amended Sep 8, 2026$6,885,000of $10.3M target22$312KDebt, Options, Securities on exerciseRule 506(b)Form D/A ↗3 earlier filings

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Klothea BIO's Form D filed Sep 8, 2026.

OJ
Olivier Jarry
Executive officer
Also a director at OS Therapies.
WS
Walter Schmidt
Director
Also a director at ADvantage Therapeutics.
Petr Sramek
Petr Sramek
Director
Also a director at Animal Bioscience.
AI
Agustin Fernandez Santana III
Executive officer and director
Also an executive officer and director at ADvantage Therapeutics.
JM
Jeffrey Madden
President and director
Also an executive officer and director at ADvantage Therapeutics.

Sources

  1. SECKlothea Bio, Inc. Form D/A, filed May 28, 2026
  2. SECKlothea Bio, Inc. Form D/A, filed Feb 2, 2026
  3. SECKlothea Bio, Inc. Form D, filed Oct 28, 2024
  4. SECKlothea Bio, Inc. filing history